...
首页> 外文期刊>World journal of gastroenterology : >Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.
【24h】

Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma.

机译:肝细胞自发破裂的预测因素和临床结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To determine the risk factors for hepatocellular carcinoma (HCC) rupture, and report the management and long-term survival results of patients with spontaneous rupture of HCC.Among 4209 patients with HCC who were diagnosed at Eastern Hepatobiliary Surgery Hospital from April 2002 to November 2006, 200 (4.8%) patients with ruptured HCC (case group) were studied retrospectively in term of their clinical characteristics and prognostic factors. The one-stage therapeutic approach to manage ruptured HCC consisted of initial management by conservative treatment, transarterial embolization (TACE) or hepatic resection. Results of various treatments in the case group were evaluated and compared with the control group (202 patients) without ruptured HCC during the same study period. Continuous data were expressed as mean ± SD or median (range) where appropriate and compared using the unpaired t test. Categorical variables were compared using the Chi-square test with Yates correction or the Fisher exact test where appropriate. The overall survival rate in each group was determined using the Kaplan-Meier method and a log-rank test.Compared with the control group, more patients in the case group had underlying diseases of hypertension (7.5% vs 3.0%, P =0.041) and liver cirrhosis (87.5% vs 56.4%, P < 0.001), tumor size >5 cm (83.0% vs 57.4%, P < 0.001), tumor protrusion from the liver surface (66.0% vs 44.6%, P < 0.001), vascular thrombus (30.5% vs 8.9%, P < 0.001) and extrahepatic invasion (36.5% vs 12.4%, P < 0.001). On multivariate logistic regression analysis, underlying diseases of hypertension (P = 0.002) and liver cirrhosis (P < 0.001), tumor size > 5 cm (P < 0.001), vascular thrombus (P = 0.002) and extrahepatic invasion (P < 0.001) were predictive for spontaneous rupture of HCC. Among the 200 patients with spontaneous rupture of HCC, 105 patients underwent hepatic resection, 33 received TACE, and 62 were managed with conservative treatment. The median survival time (MST) of all patients with spontaneous rupture of HCC was 6 mo (range, 1-72 mo), and the overall survival at 1, 3 and 5 years were 32.5%, 10% and 4%, respectively. The MST was 12 mo (range, 1-72 mo) in the surgical group, 4 mo (range, 1-30 mo) in the TACE group and 1 mo (range, 1-19 mo) in the conservative group. Ninety-eight patients in the control group underwent hepatic resection, and the MST and median disease-free survival time were 46 mo (range, 6-93 mo) and 23 mo (range, 3-39 mo) respectively, which were much longer than that of patients with spontaneous rupture of HCC undergoing hepatic resection (P < 0.001). The 1-, 3-, and 5-year overall survival rates and the 1-, 3- and 5-year disease-free survival rates in patients with ruptured HCC undergoing hepatectomy were 57.1%, 19.0% and 7.6%, 27.6%, 14.3% and 3.8%, respectively, compared with those of 77.1%, 59.8% and 41.2%, 57.1%, 40.6% and 32.9% in 98 patients without ruptured HCC undergoing hepatectomy (P < 0.001).Prolonged survival can be achieved in selected patients undergoing one-stage hepatectomy, although the survival results were inferior to those of the patients without ruptured HCC.
机译:为了确定肝细胞癌(HCC)破裂的危险因素,并报告HCC自发性破裂的患者的治疗和长期生存结果.2002年4月至2006年11月在东部肝胆外科医院确诊的4209例HCC患者中回顾性分析了200例(4.8%)HCC破裂患者(病例组)的临床特征和预后因素。治疗破裂性肝癌的一阶段治疗方法包括通过保守治疗,经动脉栓塞(TACE)或肝切除术进行初步治疗。评估病例组中各种治疗的结果,并与同期研究期间未破裂HCC的对照组(202例患者)进行比较。连续数据在适当的情况下表示为平均值±标准差或中位数(范围),并使用未配对的t检验进行比较。分类变量在适当的情况下使用卡方检验和Yates校正或Fisher精确检验进行比较。使用Kaplan-Meier方法和对数秩检验确定每组的总生存率。与对照组相比,病例组中更多的患者患有潜在的高血压病(7.5%vs 3.0%,P = 0.041)和肝硬化(87.5%vs 56.4%,P <0.001),肿瘤尺寸> 5 cm(83.0%vs 57.4%,P <0.001),肿瘤从肝表面突出(66.0%vs 44.6%,P <0.001),血管血栓(30.5%vs 8.9%,P <0.001)和肝外侵袭(36.5%vs 12.4%,P <0.001)。在多因素logistic回归分析中,高血压(P = 0.002)和肝硬化(P <0.001),肿瘤大小> 5 cm(P <0.001),血管血栓(P = 0.002)和肝外侵袭(P <0.001)的潜在疾病可预示肝癌自发性破裂。在200例肝癌自发性破裂患者中,有105例接受了肝切除术,其中33例接受了TACE,62例接受了保守治疗。所有HCC自发性破裂患者的中位生存时间(MST)为6 mo(范围为1-72 mo),在1、3和5年时的总生存率分别为32.5%,10%和4%。手术组的MST为12 mo(范围1-72 mo),TACE组为4 mo(范围1-30 mo),保守组为1 mo(范围1-19 mo)。对照组中有98例患者进行了肝切除术,MST和中位无病生存时间分别为46 mo(6-93 mo)和23 mo(3-39 mo),并且更长较肝切除自发性肝癌破裂的患者要高(P <0.001)。接受肝切除术的HCC破裂患者的1年,3年和5年总生存率以及1年,3年和5年无病生存率分别为57.1%,19.0%和7.6%,27.6%,肝切除术未破裂的98例肝癌患者中,分别为14.3%和3.8%,分别为77.1%,59.8%和41.2%,57.1%,40.6%和32.9%(P <0.001)。接受一期肝切除术的患者,尽管其生存结果不如未破裂HCC的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号